Literature DB >> 24189619

Isolation and characterization of a new Staphylococcus epidermidis broad-spectrum bacteriophage.

Luís D R Melo1, Sanna Sillankorva1, Hans-Wolfgang Ackermann2, Andrew M Kropinski3,4, Joana Azeredo1, Nuno Cerca1.   

Abstract

Staphylococcus epidermidis is considered an important nosocomial pathogen, being very tolerant to the host immune system and antibiotherapy, particularly when in biofilms. Due to its high resistance, alternative antimicrobial strategies are under development. The use of bacteriophages is seen as an important strategy to combat pathogenic organisms. In this study, a S. epidermidis myovirus, SEP1, was isolated and characterized. The genome of this phage was sequenced and shown to be related peripherally to the genus Twortlikevirus. However, when compared with other phages of this genus, it showed DNA sequence identities no greater than 58.2 %. As opposed to other polyvalent viruses of the genus Twortlikevirus, SEP1 is highly specific to S. epidermidis strains. The good infectivity shown by this phage as well as its high lytic spectrum suggested that it might be a good candidate for therapeutic studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24189619     DOI: 10.1099/vir.0.060590-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

1.  Two Phages, phiIPLA-RODI and phiIPLA-C1C, Lyse Mono- and Dual-Species Staphylococcal Biofilms.

Authors:  Diana Gutiérrez; Dieter Vandenheuvel; Beatriz Martínez; Ana Rodríguez; Rob Lavigne; Pilar García
Journal:  Appl Environ Microbiol       Date:  2015-03-06       Impact factor: 4.792

2.  Discovery of the First Lytic Staphylococcus pseudintermedius/Staphylococcus aureus Polyvalent Bacteriophages.

Authors:  Haroldo Hernandez Santos; Justin Clark; Austen Terwilliger; Anthony Maresso
Journal:  Phage (New Rochelle)       Date:  2022-06-16

3.  The interactions of bacteriophage Ace and Shiga toxin-producing Escherichia coli during biocontrol.

Authors:  Graça Pinto; Scott A Minnich; Carolyn J Hovde; Hugo Oliveira; Hauke Smidt; Carina Almeida; Joana Azeredo
Journal:  FEMS Microbiol Ecol       Date:  2021-08-03       Impact factor: 4.194

4.  Phage mobility is a core determinant of phage-bacteria coexistence in biofilms.

Authors:  Emilia L Simmons; Knut Drescher; Carey D Nadell; Vanni Bucci
Journal:  ISME J       Date:  2017-11-10       Impact factor: 11.217

5.  Synergistic Antimicrobial Interaction between Honey and Phage against Escherichia coli Biofilms.

Authors:  Ana Oliveira; Henrique G Ribeiro; Ana C Silva; Maria D Silva; Jessica C Sousa; Célia F Rodrigues; Luís D R Melo; Ana F Henriques; Sanna Sillankorva
Journal:  Front Microbiol       Date:  2017-12-08       Impact factor: 5.640

6.  Novel phages of healthy skin metaviromes from South Africa.

Authors:  Leonardo Joaquim van Zyl; Yoonus Abrahams; Emily Amor Stander; Bronwyn Kirby-McCollough; Roland Jourdain; Cécile Clavaud; Lionel Breton; Marla Trindade
Journal:  Sci Rep       Date:  2018-08-16       Impact factor: 4.379

Review 7.  Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth.

Authors:  Paul Hyman
Journal:  Pharmaceuticals (Basel)       Date:  2019-03-11

8.  Efficacy and safety assessment of two enterococci phages in an in vitro biofilm wound model.

Authors:  Luís D R Melo; R Ferreira; Ana R Costa; H Oliveira; J Azeredo
Journal:  Sci Rep       Date:  2019-04-30       Impact factor: 4.379

9.  Development of a Phage Cocktail to Control Proteus mirabilis Catheter-associated Urinary Tract Infections.

Authors:  Luís D R Melo; Patrícia Veiga; Nuno Cerca; Andrew M Kropinski; Carina Almeida; Joana Azeredo; Sanna Sillankorva
Journal:  Front Microbiol       Date:  2016-06-28       Impact factor: 5.640

10.  Characterization of a New Staphylococcus aureus Kayvirus Harboring a Lysin Active against Biofilms.

Authors:  Luís D R Melo; Ana Brandão; Ergun Akturk; Silvio B Santos; Joana Azeredo
Journal:  Viruses       Date:  2018-04-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.